Literature DB >> 24238059

Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism.

Sara E Murray1, Priya R Pathak, David S Pontes, David F Schneider, Sarah C Schaefer, Herbert Chen, Rebecca S Sippel.   

Abstract

BACKGROUND: The timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism (PHPT) has not been well characterized.
METHODS: This prospective study involved administering a questionnaire to patients with PHPT who underwent curative parathyroidectomy over an 11-month period. The questionnaire evaluated the frequency of 18 symptoms of PHPT on a 5-point Likert scale and was administered preoperatively and 1 week, 6 weeks, and 6 months postoperatively.
RESULTS: Of 197 eligible patients, 132 (67%) participated in the study. The questionnaires were completed at a rate of 91%, 92%, and 86% at 1 week, 6 weeks, and 6 months postoperatively, respectively. The most commonly reported preoperative symptoms were fatigue (98%), muscle aches (89%), and bone/joint pain (87%). Improvement in symptom severity occurred across all symptoms and was separated into three categories based on the timing of improvement. Fatigue and bone/joint pain demonstrated "Immediate Improvement" (>50% of patients reporting improvement by post-operative week 1), whereas the majority of symptoms showed peak improvement at 6 weeks ("Delayed Improvement"). Symptoms categorized as "Continuous Improvement" were those showing progressive improvement up to 6 months postoperatively (polydipsia, headaches, and nausea/vomiting).
CONCLUSION: Symptom improvement was most prominent 6 weeks postparathyroidectomy, although some symptoms showed continued improvement at 6 months.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24238059      PMCID: PMC3860985          DOI: 10.1016/j.surg.2013.09.005

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

1.  Pasieka Illness Questionnaire: its value in primary hyperparathyroidism.

Authors:  Benedikt Greutelaers; Katrin Kullen; James Kollias; Melissa Bochner; Anthony Roberts; Garry Wittert; Janice Pasieka; Peter Malycha
Journal:  ANZ J Surg       Date:  2004-03       Impact factor: 1.872

2.  Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Preethi Gopinath; Gregory P Sadler; Radu Mihai
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

3.  The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study.

Authors:  Janice L Pasieka; Louise Parsons; Jean Jones
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

4.  Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.

Authors:  Nancy D Perrier; Dave Balachandran; Jeffrey S Wefel; Camilo Jimenez; Naifa Busaidy; George S Morris; Wenli Dong; Edward Jackson; Storm Weaver; Swaroop Gantela; Douglas B Evans; Elizabeth G Grubbs; Jeffrey E Lee
Journal:  Surgery       Date:  2009-10-30       Impact factor: 3.982

5.  The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism.

Authors:  Sanziana A Roman; Julie Ann Sosa; Robert H Pietrzak; Peter J Snyder; Daniel C Thomas; Robert Udelsman; Linda Mayes
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

6.  Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey.

Authors:  G B Talpos; H G Bone; M Kleerekoper; E R Phillips; M Alam; M Honasoge; G W Divine; D S Rao
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

7.  Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Janice L Pasieka; Louise L Parsons; Michael J Demeure; Stuart Wilson; Peter Malycha; Jean Jones; Beth Krzywda
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

8.  Symptoms of gastroesophageal reflux disease improve after parathyroidectomy.

Authors:  Alexandra E Reiher; Haggi Mazeh; Sarah Schaefer; Jon Gould; Herbert Chen; Rebecca S Sippel
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

9.  Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism?

Authors:  Mark S Sywak; Sarah T Knowlton; Janice L Pasieka; Louise L Parsons; Jean Jones
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

10.  The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?

Authors:  Monica S Eigelberger; W Keat Cheah; Philip H G Ituarte; Leanne Streja; Quan-Yang Duh; Orlo H Clark
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

View more
  6 in total

1.  Elevated parathyroid hormone after parathyroidectomy delays symptom improvement.

Authors:  Priya R Pathak; Sara E Holden; Sarah C Schaefer; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2014-03-02       Impact factor: 2.192

Review 2.  Primary hyperparathyroidism.

Authors:  Tarıq Madkhali; Amal Alhefdhi; Herbert Chen; Dawn Elfenbein
Journal:  Ulus Cerrahi Derg       Date:  2016-03-01

3.  The impact of patient age on practice patterns and outcomes for primary hyperparathyroidism.

Authors:  Whitney Sutton; Joseph K Canner; Jessica B Shank; Abbey L Fingeret; Shkala Karzai; Dorry L Segev; Jason D Prescott; Aarti Mathur
Journal:  Am J Surg       Date:  2022-03-19       Impact factor: 3.125

Review 4.  Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism?

Authors:  Alexandria D McDow; Rebecca S Sippel
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2018-06-27

Review 5.  Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism.

Authors:  Giovanni Lombardi; Ewa Ziemann; Giuseppe Banfi; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

Review 6.  Irisin and Secondary Osteoporosis in Humans.

Authors:  Roberta Zerlotin; Angela Oranger; Patrizia Pignataro; Manuela Dicarlo; Filippo Maselli; Giorgio Mori; Silvia Concetta Colucci; Maria Grano; Graziana Colaianni
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.